Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. (Q44778724)
Jump to navigation
Jump to search
scientific article published on 17 March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. |
scientific article published on 17 March 2004 |
Statements
Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae (English)
Haemophilus influenzae
1 reference
Gustavo M Bertot
Carlos A Guzmán